Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karina L Bursch

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|October 20, 2023
Analysis of continuous enzyme kinetic data using ICEKATKarina L Bursch, Michael D Olp, Brian C Smith
Molecules (Basel, Switzerland)|March 13, 2024
Current Trends in Sirtuin Activator and Inhibitor DevelopmentKarina L Bursch, Christopher J Goetz, Brian C Smith
The Journal of Biological Chemistry|June 12, 2025
BET bromodomain inhibitors attenuate transcription of a subset of IL-1-induced NF-κB targets that promote inflammation in β-cellsJoshua A Nord, Savannah J Makowski, Paul F W Sidlowski, et al.
The Journal of Biological Chemistry|February 12, 2025
Multivalent nucleosome scaffolding by bromodomain and extraterminal domain tandem bromodomainsMichael D Olp, Karina L Bursch, Sarah L Wynia-Smith, et al.
ACS Medicinal Chemistry Letters|October 15, 2025
Polybromo‑1 Bromodomain Inhibitor Selectivity Is Mediated by a Unique Ligand-Binding PocketRaymundo Nuñez, Karina L Bursch, Savannah J Makowski, et al.
The Journal of Biological Chemistry|March 9, 2024
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppressionKarina L Bursch, Christopher J Goetz, Guanming Jiao, et al.
Journal of Medicinal Chemistry|October 13, 2022
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment ScreeningShifali Shishodia, Raymundo Nuñez, Brayden P Strohmier, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|October 20, 2023
Analysis of continuous enzyme kinetic data using ICEKATKarina L Bursch, Michael D Olp, Brian C Smith
Molecules (Basel, Switzerland)|March 13, 2024
Current Trends in Sirtuin Activator and Inhibitor DevelopmentKarina L Bursch, Christopher J Goetz, Brian C Smith
The Journal of Biological Chemistry|June 12, 2025
BET bromodomain inhibitors attenuate transcription of a subset of IL-1-induced NF-κB targets that promote inflammation in β-cellsJoshua A Nord, Savannah J Makowski, Paul F W Sidlowski, et al.
The Journal of Biological Chemistry|February 12, 2025
Multivalent nucleosome scaffolding by bromodomain and extraterminal domain tandem bromodomainsMichael D Olp, Karina L Bursch, Sarah L Wynia-Smith, et al.
ACS Medicinal Chemistry Letters|October 15, 2025
Polybromo‑1 Bromodomain Inhibitor Selectivity Is Mediated by a Unique Ligand-Binding PocketRaymundo Nuñez, Karina L Bursch, Savannah J Makowski, et al.
The Journal of Biological Chemistry|March 9, 2024
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppressionKarina L Bursch, Christopher J Goetz, Guanming Jiao, et al.
Journal of Medicinal Chemistry|October 13, 2022
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment ScreeningShifali Shishodia, Raymundo Nuñez, Brayden P Strohmier, et al.
Pageof 1